Most clinical trials for targeted therapy in GBM have shown limited clinical success. Although recent genome-wide studies evaluating regional heterogeneity and longitudinal GBM pairs have suggested potential...

Most clinical trials for targeted therapy in GBM have shown limited clinical success. Although recent genome-wide studies evaluating regional heterogeneity and longitudinal GBM pairs have suggested potential...Read more